THC financial statements
The full income statement, balance sheet, and cash-flow statement for Tenet Healthcare Corporation (THC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 21.3B YoY+3.1% | 20.7B YoY+0.5% | 20.6B YoY+7.2% | 19.2B YoY-1.6% | 19.5B YoY+10.5% | |
| Amortization of intangibles | 166M YoY-3.5% | 172M YoY-1.1% | 174M YoY+1.2% | 172M YoY-8.5% | 188M YoY+9.3% | |
| Operating income | 3.51B YoY-41.1% | 5.96B YoY+137.3% | 2.51B YoY+7.6% | 2.33B YoY-18.7% | 2.87B YoY+44.3% | |
| Interest expense | 821M YoY-0.6% | 826M YoY-8.3% | 901M YoY+1.2% | 890M YoY-3.6% | 923M YoY-8.0% | |
| Other non-operating income | 117M YoY-7.1% | 126M YoY+563.2% | 19.0M YoY+72.7% | 11.0M YoY-21.4% | 14.0M YoY+1300.0% | |
| Equity-method income | 264M YoY+1.5% | 260M YoY+14.0% | 228M YoY+5.6% | 216M YoY-0.9% | 218M YoY+29.0% | |
| Pre-tax income | 2.80B YoY-46.6% | 5.25B YoY+224.6% | 1.62B YoY+20.2% | 1.34B YoY-28.8% | 1.89B YoY+181.4% | |
| Income tax | 433M YoY-63.4% | 1.18B YoY+286.9% | 306M YoY-11.0% | 344M YoY-16.3% | 411M YoY+523.7% | |
1.41B YoY-56.0% | 3.20B YoY+423.7% | 611M YoY+48.7% | 411M YoY-55.0% | 914M YoY+19.0% | ||
$15.49 YoY-52.6% | $32.70 YoY+472.7% | $5.71 YoY+50.7% | $3.79 YoY-55.0% | $8.42 YoY+124.5% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
7.85B YoY+2.2% | 7.68B YoY+7.2% | 7.17B YoY+19.8% | 5.98B YoY-15.5% | 7.08B YoY-1.0% | ||
29.7B YoY+2.6% | 28.9B YoY+2.2% | 28.3B YoY+4.3% | 27.2B YoY-1.5% | 27.6B YoY+1.7% | ||
4.46B YoY+3.5% | 4.31B YoY-9.5% | 4.76B YoY+6.3% | 4.48B YoY-12.4% | 5.11B YoY+5.4% | ||
20.7B YoY+1.5% | 20.4B YoY-10.6% | 22.8B YoY+1.1% | 22.5B YoY-3.3% | 23.3B YoY-3.7% | ||
4.22B YoY+1.2% | 4.17B YoY+159.4% | 1.61B YoY+40.8% | 1.14B YoY+11.1% | 1.03B YoY+3571.4% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
3.54B YoY+72.9% | 2.05B YoY-13.8% | 2.37B YoY+119.2% | 1.08B YoY-30.9% | 1.57B YoY-54.0% | ||
-1.27B YoY-137.2% | 3.43B YoY+453.9% | -969M YoY-19.9% | -808M YoY-13.2% | -714M YoY+55.6% | ||
-2.40B YoY+34.8% | -3.69B YoY-256.0% | -1.03B YoY+41.9% | -1.78B YoY-90.3% | -936M YoY-343.1% | ||
| Net change in cash | -136M YoY-107.6% | 1.79B YoY+384.1% | 370M YoY+124.6% | -1.51B YoY-1736.6% | -82.0M YoY-103.8% | |
| Interest paid | 865M YoY+1.6% | 851M YoY-3.5% | 882M YoY+4.0% | 848M YoY-9.5% | 937M YoY-2.6% | |
| Income taxes paid | 450M YoY-64.6% | 1.27B YoY+423.0% | 243M YoY+50.9% | 161M YoY+75.0% | 92.0M YoY+666.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 17.3B YoY+43.9% | 12.0B YoY+56.5% | 7.67B YoY+45.5% | 5.28B YoY-39.9% | 8.77B YoY+106.9% | |
| P/E | 12.3× YoY+227.3% | 3.8× YoY-77.1% | 16.4× YoY+73.1% | 9.5× YoY-1.5% | 9.6× YoY+73.9% | |
| P/S | 0.8× YoY+39.6% | 0.6× YoY+52.6% | 0.4× YoY+37.4% | 0.3× YoY-38.5% | 0.5× YoY+87.3% | |
| P/B | 4.1× YoY+42.3% | 2.9× YoY-45.1% | 5.2× YoY+22.7% | 4.3× YoY-50.0% | 8.5× YoY-94.4% | |
| P/FCF | 6.8× YoY-36.5% | 10.8× YoY+59.5% | 6.7× YoY-68.9% | 21.7× YoY+125.1% | 9.6× YoY+552.0% | |
8.1% YoY-69.5% | 26.7% YoY+336.1% | 6.1% YoY-42.2% | 10.6% YoY+1.5% | 10.4% YoY-42.5% | ||
14.6% YoY+57.5% | 9.3% YoY-37.3% | 14.8% YoY+221.9% | 4.6% YoY-55.6% | 10.4% YoY-84.7% | ||
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: THC's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all THC filings on SEC EDGAR → Not investment advice.
